Abstract
p53 is involved in several DNA repair pathways. Some of these require the specific transactivation of p53-dependent genes and others involve direct interactions between the p53 protein and DNA repair associated proteins. Previously, we have shown that p53 acts directly in Base Excision Repair (BER) when assayed under in vitro conditions. Our present data indicate that this involvement is independent of the transcriptional activity of the p53 molecule. We found that under both in vitro and in vivo conditions, a p53 transactivation-deficient molecule, p53-22-23 was more efficient in BER activity than was wild type p53. However, mutations in the core domain or C-terminal alterations strongly reduced p53-mediated BER activity. These results are consistent with the hypothesis that the involvement of p53 in BER activity, a housekeeping DNA repair pathway, is a prompt and immediate one that does not involve the activation of p53 transactivation-dependent mechanisms, but rather concerns with the p53 protein itself. In an endogenous DNA damage status p53 is active in BER pathways as a protein and not as a transcription factor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abramova NA, Russell J, Botchan M and Li R. . 1997 Proc. Natl. Acad. Sci. USA 94: 7186–7191.
Caelles C, Helmberg A and Karin M. . 1994 Nature 370: 220–223.
Chang J, Kim DH, Lee SW, Choi KY and Sung YC. . 1995 J. Biol. Chem. 270: 25014–25019.
Chen I-T, Smith ML, O'Connor PM and Fornace AJJ. . 1995 Oncogene 11: 1931–1937.
Donehower LA. . 1996 Semin. Cancer Biol. 7: 269–278.
Dutta A, Ruppert JM, Aster JC and Wincherester E. . 1993 Nature 365: 79–82.
Farmer G, Colgan J, Nakatani Y, Manley JL and Prives C. . 1996 Mol. Cell. Biol. 16: 4295–4304.
Flores-Rozas H, Kelman Z, Dean F, Pau Z, Harper W, Elledge S, O'donell M and Hurowitz J. . 1994 Proc. Natl. Acad. Sci. USA 91: 8655–8659.
Frosina G, Fortini P, Rossi O, Carrozzino F, Raspaglio G, Cox LS, Lane DP, Abbondandolo A and Sogliotti E. . 1996 J. Biol. Chem. 271: 9573–9578.
Gaiddon C, Moorthy NC and Prives C. . 1999 EMBO J. 18: 5609–5621.
Gottlieb TM and Oren M. . 1998 Semin. Cancer Biol. 8: 359–368.
Grombacher T, Eichhorn U and Kaina B. . 1998 Oncogene 17: 845–851.
Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M. . 1995 Genes Dev. 9: 2170–2183.
Henderson EE, Valerie K, Green AP and de Riel JK. . 1989 Mutat Res. 220: 151–160.
Hollstein M, Sidransky D, Vogelstein B and Harris CC. . 1991 Science 253: 49–53.
Hunger HD, Schmidt G and Flachmeier C. . 1994 Anal. Biochem. 217: 98–102.
Hussain SP and Harris CC. . 1998 Cancer Res. 58: 4023–4037.
Hwang BJ, Ford JM, Hanawalt PC and Chu G. . 1999 Proc. Natl. Acad. Sci. USA 96: 424–428.
Janus F, Albrechtsen N, Dornreiter I, Wiesmuller L, Grosse F and Deppert W. . 1999a Cell. Mol. Life Sci. 55: 12–27.
Janus F, Albrechtsen N, Knippschild U, Wiesmuller L, Grosse F and Deppert W. . 1999b Mol. Cell. Biol. 19: 2155–2168.
Kaneko Y and Tsukamoto A. . 1995 Cancer Lett. 91: 11–17.
Kastan MB, Radin AI, Kuerbitz SJ, Onyekwere O, Wolkow CA, Civin CI, Stone KD, Woo T, Ravindranath Y and Craig RW. . 1991 Cancer Res. 51: 4279–4286.
Lin J, Chen J, Elenbaas B and Levine AJ. . 1994 Genes Dev. 8: 1235–1246.
Lindahl T. . 1993 Nature 362: 709–715.
Lloyd DR and Hanawalt PC. . 2000 Cancer Res. 60: 517–521.
McKay BC, Ljungman M and Rainbow AJ. . 1999 Carcinogenesis 20: 1389–1396.
Miller SD, Moses K, Jayaraman L and Prives C. . 1997 Mol. Cell. Biol. 17: 2194–2201.
Mummenbrauer T, Janus F, Muller B, Wiesmuller L, Deppert W and Grosse F. . 1996 Cell 85: 1089–1099.
Myung K, Braastad C, He DM and Hendrickson EA. . 1998 Proc. Natl. Acad. Sci. USA 95: 7664–7669.
Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z and Rotter V. . 1999 FEBS Lett. 450: 197–204.
Oliver FJ, Menissier-de Murcia J and de Murcia G. . 1999 Am. J. Hum. Genet. 64: 1282–1288.
Peled A, Zipori D and Rotter V. . 1996 Cancer Res. 56: 2148–2156.
Raycroft L, Wu H and Lozano G. . 1990 Science 249: 1049–1051.
Ronen D, Schwartz D, Teitz Y, Goldfinger N and Rotter V. . 1996 Cell Growth Differ. 7: 21–30.
Seeberg E, Eide L and Bjoras M. . 1995 Trends Biochem. Sci. 20: 391–397.
Shivji M, Grey S, Strausfeld U, Wood R and Blow J. . 1994 Curr. Biol. 4: 1062–1068.
Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y and Nakamura Y. . 2000 Nature 404: 42–49.
Tang W, Willers H and Powell SN. . 1999 Cancer Res. 59: 2562–2565.
Therrien JP, Drouin R, Baril C and Drobetsky EA. . 1999 Proc. Natl. Acad. Sci. USA 96: 15038–15043.
Wang XW, Forrester K, Yeh H, Feitelson MA, Gu J and Harris C. . 1994a Proc. Natl. Acad. Sci. USA 91: 2230–2234.
Wang XW, Yeh H, Schaeffer L, Roy R, Moncolli V, Egly J-M, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K and Harris CC. . 1995 Nat. Genetics 10: 188–195.
Wang Z, Svejstrup JQ, Feaver WJ, Wu X, Kornberg RD and Friedberg EC. . 1994b Nature 368: 74–76.
Wani MA, Zhu QZ, El-Mahdy M and Wani AA. . 1999 Carcinogenesis 20: 765–772.
White E. . 1996 Genes Dev. 10: 1–15.
Yang T, Namba H, Hara T, Takmura N, Nagayama Y, Fukata S, Ishikawa N, Kuma K, Ito K and Yamashita S. . 1997 Oncogene 14: 1511–1519.
Yee JK, Friedmann T and Burns JC. . 1994 Methods Cell Biol. 43: 99–112.
Yokote H, Nishio K, Arioka H, Kurokawa H, Fukuoka K, Fukumoto H, Ishida T, Terada T, Itakura T and Saijo N. . 1998 Mutat. Res. 409: 147–162.
Zhou X, Wang XW, Xu L, Hagiwara K, Nagashima M, Wolkowicz R, Zurer I, Rotter V and Harris CC. . 1999 Cancer Res. 59: 843–848.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Offer, H., Milyavsky, M., Erez, N. et al. Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene 20, 581–589 (2001). https://doi.org/10.1038/sj.onc.1204120
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204120
Keywords
This article is cited by
-
Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair
Communications Biology (2021)
-
The role of DNA damage responses in p53 biology
Archives of Toxicology (2015)
-
The protein p17 signaling pathways in cancer
Tumor Biology (2013)
-
p53 in recombination and repair
Cell Death & Differentiation (2006)
-
p53: traffic cop at the crossroads of DNA repair and recombination
Nature Reviews Molecular Cell Biology (2005)